S&P 500   4,565.81 (+0.34%)
DOW   35,511.10 (+0.50%)
QQQ   390.64 (+0.38%)
AAPL   190.93 (+0.60%)
MSFT   382.79 (+1.10%)
META   336.32 (+0.48%)
GOOGL   136.71 (+0.22%)
AMZN   147.54 (-0.13%)
TSLA   242.20 (+2.59%)
NVDA   481.10 (-0.27%)
NIO   7.26 (+0.97%)
BABA   76.08 (-1.87%)
AMD   122.47 (-0.15%)
T   16.16 (-0.31%)
F   10.40 (+0.58%)
MU   75.66 (-2.39%)
CGC   0.54 (-1.96%)
GE   119.74 (-0.19%)
DIS   94.14 (-1.08%)
AMC   6.66 (-2.06%)
PFE   29.98 (-0.53%)
PYPL   57.27 (+1.56%)
XOM   104.77 (+0.78%)
S&P 500   4,565.81 (+0.34%)
DOW   35,511.10 (+0.50%)
QQQ   390.64 (+0.38%)
AAPL   190.93 (+0.60%)
MSFT   382.79 (+1.10%)
META   336.32 (+0.48%)
GOOGL   136.71 (+0.22%)
AMZN   147.54 (-0.13%)
TSLA   242.20 (+2.59%)
NVDA   481.10 (-0.27%)
NIO   7.26 (+0.97%)
BABA   76.08 (-1.87%)
AMD   122.47 (-0.15%)
T   16.16 (-0.31%)
F   10.40 (+0.58%)
MU   75.66 (-2.39%)
CGC   0.54 (-1.96%)
GE   119.74 (-0.19%)
DIS   94.14 (-1.08%)
AMC   6.66 (-2.06%)
PFE   29.98 (-0.53%)
PYPL   57.27 (+1.56%)
XOM   104.77 (+0.78%)
S&P 500   4,565.81 (+0.34%)
DOW   35,511.10 (+0.50%)
QQQ   390.64 (+0.38%)
AAPL   190.93 (+0.60%)
MSFT   382.79 (+1.10%)
META   336.32 (+0.48%)
GOOGL   136.71 (+0.22%)
AMZN   147.54 (-0.13%)
TSLA   242.20 (+2.59%)
NVDA   481.10 (-0.27%)
NIO   7.26 (+0.97%)
BABA   76.08 (-1.87%)
AMD   122.47 (-0.15%)
T   16.16 (-0.31%)
F   10.40 (+0.58%)
MU   75.66 (-2.39%)
CGC   0.54 (-1.96%)
GE   119.74 (-0.19%)
DIS   94.14 (-1.08%)
AMC   6.66 (-2.06%)
PFE   29.98 (-0.53%)
PYPL   57.27 (+1.56%)
XOM   104.77 (+0.78%)
S&P 500   4,565.81 (+0.34%)
DOW   35,511.10 (+0.50%)
QQQ   390.64 (+0.38%)
AAPL   190.93 (+0.60%)
MSFT   382.79 (+1.10%)
META   336.32 (+0.48%)
GOOGL   136.71 (+0.22%)
AMZN   147.54 (-0.13%)
TSLA   242.20 (+2.59%)
NVDA   481.10 (-0.27%)
NIO   7.26 (+0.97%)
BABA   76.08 (-1.87%)
AMD   122.47 (-0.15%)
T   16.16 (-0.31%)
F   10.40 (+0.58%)
MU   75.66 (-2.39%)
CGC   0.54 (-1.96%)
GE   119.74 (-0.19%)
DIS   94.14 (-1.08%)
AMC   6.66 (-2.06%)
PFE   29.98 (-0.53%)
PYPL   57.27 (+1.56%)
XOM   104.77 (+0.78%)

BioSig Technologies Stock Price, News & Analysis (NASDAQ:BSGM)

$0.31
+0.00 (+0.91%)
(As of 11:45 AM ET)
Compare
Today's Range
$0.30
$0.32
50-Day Range
$0.31
$0.63
52-Week Range
$0.28
$1.65
Volume
23,826 shs
Average Volume
445,634 shs
Market Capitalization
$27.31 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00

BioSig Technologies MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
1,512.9% Upside
$5.00 Price Target
Short Interest
Healthy
2.30% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.21mentions of BioSig Technologies in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.06 out of 5 stars

Medical Sector

760th out of 935 stocks

Electromedical Equipment Industry

17th out of 22 stocks


BSGM stock logo

About BioSig Technologies Stock (NASDAQ:BSGM)

BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

BSGM Stock Price History

BSGM Stock News Headlines

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Americans Now Favor Gold Over Stocks as an Investment Vehicle
Americans now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges.
Why Is BioSig Technologies (BSGM) Stock Up 19% Today?
BioSig Joins Webull Corporate Connect
Biosig Tech (BSGM) Earnings Dates & Reports
BioSig Announces New Advisory Board Member Edwin Wang
BioSig Confirms No Exposure to Silicon Valley Bank
See More Headlines
Receive BSGM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioSig Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/31/2022
Today
11/28/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/13/2024

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:BSGM
Fax
N/A
Employees
47
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.00
High Stock Price Target
$5.00
Low Stock Price Target
$5.00
Potential Upside/Downside
+1,527.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-27,050,000.00
Net Margins
-9,336.04%
Pretax Margin
-20,963.12%

Debt

Sales & Book Value

Annual Sales
$290,000.00
Book Value
$0.01 per share

Miscellaneous

Free Float
79,914,000
Market Cap
$27.07 million
Optionable
Not Optionable
Beta
1.29
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Kenneth L. Londoner M.B.A.Mr. Kenneth L. Londoner M.B.A. (Age 55)
    Founder, CEO & Executive Chairman
    Comp: $1.17M
  • Mr. John Sieckhaus (Age 55)
    Chief Operating Officer
    Comp: $282.52k
  • Mr. Michael Graydon Fleming Jr. (Age 49)
    Chief Commercial Officer
    Comp: $400k
  • Mr. Frederick D. Hrkac (Age 57)
    Executive VP & Director
    Comp: $15k
  • Mr. Steven J. Buhaly (Age 66)
    Chief Financial Officer
  • Dr. Budimir S. Drakulic Ph.D. (Age 73)
    Chief Scientist
    Comp: $169.64k
  • Mr. Andrew Gornell Ballou
    Vice President of Investor Relations
  • Ms. Brenda Castrodad
    Vice President of Human Resources














BSGM Stock Analysis - Frequently Asked Questions

Should I buy or sell BioSig Technologies stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for BioSig Technologies in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BSGM shares.
View BSGM analyst ratings
or view top-rated stocks.

What is BioSig Technologies' stock price target for 2024?

2 brokers have issued twelve-month price objectives for BioSig Technologies' stock. Their BSGM share price targets range from $5.00 to $5.00. On average, they predict the company's stock price to reach $5.00 in the next twelve months. This suggests a possible upside of 1,512.9% from the stock's current price.
View analysts price targets for BSGM
or view top-rated stocks among Wall Street analysts.

How have BSGM shares performed in 2023?

BioSig Technologies' stock was trading at $0.42 at the beginning of 2023. Since then, BSGM stock has decreased by 26.2% and is now trading at $0.31.
View the best growth stocks for 2023 here
.

When is BioSig Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 13th 2024.
View our BSGM earnings forecast
.

How were BioSig Technologies' earnings last quarter?

BioSig Technologies, Inc. (NASDAQ:BSGM) released its earnings results on Thursday, March, 31st. The company reported ($0.24) earnings per share for the quarter, missing analysts' consensus estimates of ($0.22) by $0.02. BioSig Technologies had a negative net margin of 9,336.04% and a negative trailing twelve-month return on equity of 8,125.85%.

What other stocks do shareholders of BioSig Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioSig Technologies investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Roku (ROKU), Advanced Micro Devices (AMD), Amarin (AMRN), Dynavax Technologies (DVAX), Vaxart (VXRT), Telefonaktiebolaget LM Ericsson (publ) (ERIC) and Micron Technology (MU).

Who are BioSig Technologies' major shareholders?

BioSig Technologies' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Advisor Resource Council (1.44%), PFG Investments LLC (0.19%), Warberg Asset Management LLC (0.09%), Group One Trading L.P. (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Gray Fleming, Jeffrey F Odonnell, John Sieckhaus, Kenneth L Londoner, Kenneth L Londoner, Patrick Joseph Gallagher and Steve Chaussy.
View institutional ownership trends
.

How do I buy shares of BioSig Technologies?

Shares of BSGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:BSGM) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -